PS Ratio
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- ONTX price to sales ratio is not available.
Performance
ONTX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
ONTX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | - | - | 0.0% |
| 3 m3 months | - | - | - | 0.0% |
| 6 m6 months | - | - | - | - |
| 1 y1 year | - | - | - | 0.0% |
| 5 y5 years | - | - | - | 0.0% |
ONTX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | 95.72 | 53.34 | ||
| 3 y | 3-year | 183.07 | 53.34 | ||
| 5 y | 5-year | 1802.01 | 21.63 | ||
| alltime | all time | 1802.01 | 0.56 |
Onconova Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2023 | 67.84(+12.7%) |
| 2022 | 60.19(-74.5%) |
| 2021 | 235.77(-37.7%) |
| 2020 | 378.33(+1855.2%) |
| 2019 | 19.35(+98.5%) |
| Date | Value |
|---|---|
| 2018 | 9.75(-52.5%) |
| 2017 | 20.54(+644.2%) |
| 2016 | 2.76(+29.6%) |
| 2015 | 2.13(-97.6%) |
| 2014 | 88.83(+72.1%) |
| 2013 | 51.63 |
FAQ
- What is the all time high PS ratio for Onconova Therapeutics?
What is the all time high PS ratio for Onconova Therapeutics?
Onconova Therapeutics all-time high price to sales ratio is 1802.01